Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

99.13

+0.13 (0.13%)

At close: Mar 17, 2026, 4:00 PM EDT

99.80

+0.67 (0.68%)

After-hours: Mar 17, 2026, 7:38 PM EDT

Revolution Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	383.75	543.06	696.15	161.41	108.5
Short-Term Investments	1,642	1,746	1,157	483.53	468.56
Cash & Short-Term Investments	2,026	2,289	1,853	644.94	577.05
Cash Growth	-11.52%	23.55%	187.31%	11.77%	30.93%
Accounts Receivable	-	-	1.25	4.67	5.93
Other Current Assets	49.36	38.33	25.07	10.57	6.79
Total Current Assets	2,075	2,328	1,879	660.19	589.77
Net Property, Plant & Equipment	165.28	141.82	100.01	73.74	71.24
Other Intangible Assets	55.8	56.67	57.74	58.81	59.88
Goodwill	14.61	14.61	14.61	14.61	14.61
Other Long-Term Assets	43.79	17.57	10.06	4.59	2.5
Total Assets	2,355	2,558	2,062	811.93	737.99
Accounts Payable	64.62	54.43	61.79	21.31	14.06
Accrued Expenses	209.34	96.62	74.69	29.45	27.72
Current Portion of Leases	16.47	12.87	7.37	6.77	6.21
Unearned Revenue	-	-	-	4.46	12.36
Other Current Liabilities	209.34	96.62	74.69	29.45	27.72
Total Current Liabilities	290.42	163.91	143.85	61.98	60.35
Long-Term Leases	142.23	122.97	80.58	57.43	60.42
Other Long-Term Liabilities	290.02	6.75	11.09	7.33	14.65
Total Long-Term Liabilities	432.25	129.72	91.66	64.76	75.07
Total Liabilities	723.21	293.1	235.51	126.74	135.42
Common Stock	0.02	0.02	0.02	0.01	0.01
Additional Paid-in Capital	4,497	4,002	2,963	1,388	1,056
Accumulated Other Comprehensive Income	3.24	1.32	0.54	-1.78	-0.38
Retained Earnings	-2,869	-1,738	-1,138	-701.34	-452.64
Shareholders' Equity	1,631	2,265	1,826	685.19	602.57
Total Liabilities & Equity	2,355	2,558	2,062	811.93	737.99
Total Debt	158.7	135.84	87.94	64.21	66.63
Net Cash (Debt)	1,867	2,153	1,765	580.74	510.42
Net Cash Growth	-13.30%	22.01%	203.93%	13.78%	25.08%
Net Cash Per Share	9.82	12.84	15.60	7.20	7.01
Book Value	1,631	2,265	1,826	685.19	602.57
Book Value Per Share	8.58	13.50	16.14	8.50	8.28
Tangible Book Value	1,561	2,194	1,754	611.77	528.08
Tangible Book Value Per Share	8.21	13.08	15.50	7.59	7.25

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q